Goodrich Lab (Colorado State University)
Goodrich Lab at Colorado State University focuses on research for treating and preventing disease transmission, with emphasis on vaccine development and pathogen inactivation using photochemical methods. The lab conducts both fundamental and translational research ranging from device prototyping and animal studies to clinical trial readiness. Disease targets include SARS-CoV-2, tuberculosis, various strains of influenza, African swine fever, and cancer immunotherapy.
Industries
N/A
Nr. of Employees
small (1-50)
Goodrich Lab (Colorado State University)
Office: D210, Colorado State University
Products
Vaccine candidates for infectious diseases
Vaccine formulations developed for diseases such as SARS-CoV-2, human and avian influenza, tuberculosis, and African swine fever, designed and tested in various animal models.
Photochemical devices for pathogen inactivation and vaccine manufacturing
Prototype devices enabling photochemical inactivation of pathogens in blood products and large-scale vaccine batch processing.
Cancer immunotherapy approach using light-inactivated tumor cells
Experimental immunotherapy strategy using whole, light-inactivated tumor cells derived from the patient to stimulate an immune response against cancer.
Vaccine candidates for infectious diseases
Vaccine formulations developed for diseases such as SARS-CoV-2, human and avian influenza, tuberculosis, and African swine fever, designed and tested in various animal models.
Photochemical devices for pathogen inactivation and vaccine manufacturing
Prototype devices enabling photochemical inactivation of pathogens in blood products and large-scale vaccine batch processing.
Cancer immunotherapy approach using light-inactivated tumor cells
Experimental immunotherapy strategy using whole, light-inactivated tumor cells derived from the patient to stimulate an immune response against cancer.
Expertise Areas
- Vaccine development
- Pathogen inactivation
- Transfusion medicine
- Animal model studies
Key Technologies
- Photochemical inactivation
- Vaccine formulation
- Animal model testing
- GMP manufacturing
Key People
Principal Investigator, Professor
Research Scientist I
Research Scientist
Graduate Research Assistant
Student Researcher
Student Researcher
Principal Investigator, Professor
Research Scientist I
Research Scientist
Graduate Research Assistant
Student Researcher
Student Researcher
News & Updates
Professor Ray Goodrich won the Dale Smith Memorial Award for the development and implementation of pathogen-reduction technology.
Dr. Ray Goodrich received a grant to develop a device for treating blood products to prevent transfusion-transmitted diseases.
Coverage on new clinical trial of light-inactivated tumor cell immunotherapy led by Dr. Ray Goodrich.
Development of cancer immunotherapy using patient’s tumor cells to train the immune system by Dr. Raymond Goodrich.
Team led by Dr. Ray Goodrich gets approval to begin human trials on a new cancer immunotherapy.
Features the team’s work on personalized immunotherapy for ovarian cancer patients.
Professor Ray Goodrich won the Dale Smith Memorial Award for the development and implementation of pathogen-reduction technology.
Dr. Ray Goodrich received a grant to develop a device for treating blood products to prevent transfusion-transmitted diseases.
Coverage on new clinical trial of light-inactivated tumor cell immunotherapy led by Dr. Ray Goodrich.
Development of cancer immunotherapy using patient’s tumor cells to train the immune system by Dr. Raymond Goodrich.
Team led by Dr. Ray Goodrich gets approval to begin human trials on a new cancer immunotherapy.
Features the team’s work on personalized immunotherapy for ovarian cancer patients.